Pharmaceutical companies must adapt financing procedures by 1 July 2026 or lose SNSS funding rights
Technical details
Type
Royal Decree (what is this?)
Identifier
BOE-A-2026-3215
Published
12 Feb 2026
Entry into force
1 Jul 2026 (in force)
Summary
Royal Decree 90/2026 repeals Orders SCO/470/2002 and RD 9/1996, introducing a new selective financing process for healthcare products with SNSS pharmaceutical funding. Procedures must be updated by 1 July 2026, otherwise selective financing rights will be lost (art. 1, final disp. 6.2).
Lifecycle
2026-02-12PublishedPublished in the BOE
2026-07-01Into forceComes into force (disp. final 6.2)
BMC resources for this provision
- tax-compliance/iva-empresasView service →
Official text Based on BOE data (boe.es). Information, not advice.